Sanofi Aventis

Related topics:

Sanofi Aventis related content:

Sanofi Aventis stories:

  • Sanofi Aventis trends

  • Sanofi Expands Regeneron Deal

    Nov 10th, 2009 - Wall Street Journal

    Regeneron Pharmaceuticals Inc. and Sanofi-Aventis SA said they are expanding their drug development partnership under terms in which the French drug maker will invest...

  • Sanofi-Aventis and Regeneron Expand Research Pact

    Nov 10th, 2009 - Bloomberg

    Nov. 10 (Bloomberg) -- Sanofi-Aventis SA and RegeneronPharmaceuticals Inc. said they expanded their existing agreementto develop drugs to treat pain, cancer and arthritis...

  • Sanofi wants to double vaccine business-paper

    Oct 31st, 2009 - Reuters

    FRANKFURT, Oct 31 (Reuters) - Sanofi-Aventis (SASY.PA) wantsto double its vaccine business in the next five years, its chiefexecutive told a German newspaper on Saturday. "We want to double it in the next five years...

  • Sanofi lifts forecast on swine flu vaccine

    Oct 30th, 2009 - Reuters

    Sanofi lifts forecast on swine flu vaccinePARIS (Reuters) - Sanofi-Aventis (SASY.PA) raised its outlook for 2009 thanks to sales of swine flu vaccine and posted earnings per share growth that beat forecasts as competition from generics was offset by revenue growth for other drugs.

  • Sanofi 3Q Pft +6.8%; Ups Target On Swine Flu Vaccine

    Oct 30th, 2009 - Wall Street Journal

    Of DOW JONES NEWSWIRES PARIS (Dow Jones)--French drugs company Sanofi-Aventis SA (SNY) Friday reported a 6.8% rise in third-quarter net profit due to robust sales growth of blockbuster drugs Lantus and Lovenox...

More stories ...

Sanofi Aventis videos from YouTube:

More videos ...
 

Sanofi Aventis from WikiPedia:

Sanofi-Aventis (Euronext: SAN, NYSE: SNY), headquartered in Paris, France, is a multinational pharmaceutical company, the world's fourth-largest by prescription sales. Sanofi-Aventis engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. Sanofi-Aventis covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur). The company is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Read more on WikiPedia

Google Search: